<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Wed, 13 May 2026 09:45:31 -0400--><rss version="2.0">
    <channel>
        <title>Abeona Therapeutics Inc. (ABEO) SEC Filings</title>
        <link>https://investors.abeonatherapeutics.com/sec-filings/all-sec-filings/rss</link>
        <description>Abeona Therapeutics Inc. (ABEO) - All SEC Filings</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_798efd313b61071fa19d384f9817a343/abeonatherapeutics/files/theme/images/logo-sm.png</url>
                <title>Abeona Therapeutics Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]></title>
                <description><![CDATA[4 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32]]></description>
                <link>https://investors.abeonatherapeutics.com/sec-filings/all-sec-filings/content/0001493152-26-022614/0001493152-26-022614.pdf</link>
                <pubDate>Wed, 13 May 26 00:00:00 -0400</pubDate>
                <guid>https://investors.abeonatherapeutics.com/sec-filings/all-sec-filings/content/0001493152-26-022614/0001493152-26-022614.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[3 Related Documents: 8-K, EX-99.1, EX-99.2]]></description>
                <link>https://investors.abeonatherapeutics.com/sec-filings/all-sec-filings/content/0001493152-26-022610/0001493152-26-022610.pdf</link>
                <pubDate>Wed, 13 May 26 00:00:00 -0400</pubDate>
                <guid>https://investors.abeonatherapeutics.com/sec-filings/all-sec-filings/content/0001493152-26-022610/0001493152-26-022610.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://investors.abeonatherapeutics.com/sec-filings/all-sec-filings/content/0001493152-26-022332/0001493152-26-022332.pdf</link>
                <pubDate>Mon, 11 May 26 00:00:00 -0400</pubDate>
                <guid>https://investors.abeonatherapeutics.com/sec-filings/all-sec-filings/content/0001493152-26-022332/0001493152-26-022332.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[144 - Report of proposed sale of securities]]></title>
                <description><![CDATA[144]]></description>
                <link>https://investors.abeonatherapeutics.com/sec-filings/all-sec-filings/content/0001972481-26-000150/0001972481-26-000150.pdf</link>
                <pubDate>Mon, 11 May 26 00:00:00 -0400</pubDate>
                <guid>https://investors.abeonatherapeutics.com/sec-filings/all-sec-filings/content/0001972481-26-000150/0001972481-26-000150.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material]]></title>
                <description><![CDATA[DEFA14A]]></description>
                <link>https://investors.abeonatherapeutics.com/sec-filings/all-sec-filings/content/0001493152-26-021127/0001493152-26-021127.pdf</link>
                <pubDate>Mon, 04 May 26 00:00:00 -0400</pubDate>
                <guid>https://investors.abeonatherapeutics.com/sec-filings/all-sec-filings/content/0001493152-26-021127/0001493152-26-021127.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors]]></title>
                <description><![CDATA[SCHEDULE 13G]]></description>
                <link>https://investors.abeonatherapeutics.com/sec-filings/all-sec-filings/content/0001493152-26-019340/0001493152-26-019340.pdf</link>
                <pubDate>Tue, 28 Apr 26 00:00:00 -0400</pubDate>
                <guid>https://investors.abeonatherapeutics.com/sec-filings/all-sec-filings/content/0001493152-26-019340/0001493152-26-019340.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[ARS - Annual Report to Security Holders]]></title>
                <description><![CDATA[ARS]]></description>
                <link>https://investors.abeonatherapeutics.com/sec-filings/all-sec-filings/content/0001493152-26-019156/0001493152-26-019156.pdf</link>
                <pubDate>Mon, 27 Apr 26 00:00:00 -0400</pubDate>
                <guid>https://investors.abeonatherapeutics.com/sec-filings/all-sec-filings/content/0001493152-26-019156/0001493152-26-019156.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[DEF 14A - Definitive proxy statements]]></title>
                <description><![CDATA[DEF 14A]]></description>
                <link>https://investors.abeonatherapeutics.com/sec-filings/all-sec-filings/content/0001493152-26-019153/0001493152-26-019153.pdf</link>
                <pubDate>Mon, 27 Apr 26 00:00:00 -0400</pubDate>
                <guid>https://investors.abeonatherapeutics.com/sec-filings/all-sec-filings/content/0001493152-26-019153/0001493152-26-019153.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[PRE 14A - Preliminary proxy statement not related to a contested matter or merger/acquisition]]></title>
                <description><![CDATA[PRE 14A]]></description>
                <link>https://investors.abeonatherapeutics.com/sec-filings/all-sec-filings/content/0001493152-26-017879/0001493152-26-017879.pdf</link>
                <pubDate>Fri, 17 Apr 26 00:00:00 -0400</pubDate>
                <guid>https://investors.abeonatherapeutics.com/sec-filings/all-sec-filings/content/0001493152-26-017879/0001493152-26-017879.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://investors.abeonatherapeutics.com/sec-filings/all-sec-filings/content/0001493152-26-015456/0001493152-26-015456.pdf</link>
                <pubDate>Tue, 07 Apr 26 00:00:00 -0400</pubDate>
                <guid>https://investors.abeonatherapeutics.com/sec-filings/all-sec-filings/content/0001493152-26-015456/0001493152-26-015456.pdf</guid>
                                                                            </item>
            </channel>
</rss>